Pasotuxizumab, a Bite <sup>®</sup> Immune Therapy for Castration-Resistant Prostate Cancer: Phase I, Dose-Escalation Study Findings

DOI Web Site 1 Citations
  • Horst-Dieter Hummel
    Translational Oncology/Early Clinical Trial Unit (ECTU), Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Oberdürrbacherstr. 6, 97080Würzburg, Germany
  • Peter Kufer
    Research and Development, Amgen Research Munich GmbH, Staffelseestr. 2, 81477, Munich, Germany
  • Carsten Grüllich
    Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Medical Center, Heidelberg, Germany; & Department of Oncology & Hematology, University Hospital Dresden, Haus 27, Fetscherstr. 74, 01307Dresden, Germany
  • Ruth Seggewiss-Bernhardt
    Translational Oncology/Early Clinical Trial Unit (ECTU), Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Oberdürrbacherstr. 6, 97080Würzburg, Germany
  • Barbara Deschler-Baier
    Translational Oncology, Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Josef-Schneider-Str. 6, 97080Würzburg, Germany
  • Manik Chatterjee
    Translational Oncology/Early Clinical Trial Unit (ECTU), Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Oberdürrbacherstr. 6, 97080Würzburg, Germany
  • Maria-Elisabeth Goebeler
    Translational Oncology/Early Clinical Trial Unit (ECTU), Medizinische Klinik II, University Hospital Würzburg, Oberdürrbacherstr. 6, 97080Würzburg, Germany
  • Kurt Miller
    Department of Urology, Charité Universitätsmedizin Berlin, Charitéplatz. 1, 10117, Berlin, Germany
  • Maria de Santis
    Department of Urology, Charité Universitätsmedizin Berlin, Charitéplatz. 1, 10117, Berlin, Germany
  • Wolfgang Loidl
    Department of Urology, Ordensklinikum Linz GmbH Elisabethinen, Fadingerstr. 1, 4020, Linz, Austria
  • Christian Dittrich
    Applied Cancer Research–Institution for Translational Research Vienna (ACR-ITR VIEnna) & Center for Oncology & Hematology, Kaiser Franz Josef-Spital, Bernardgasse 24/2, 1070, Vienna, Austria
  • Andreas Buck
    Department of Nuclear Medicine, University Hospital Würzburg, Oberdürrbacherstr. 6, D-97080, Würzburg, Germany
  • Constantin Lapa
    Department of Nuclear Medicine, University Hospital Würzburg, Oberdürrbacherstr. 6, D-97080, Würzburg, Germany
  • Annette Thurner
    Department of Diagnostic & Interventional Radiology, University Hospital Würzburg, Oberdürrbacherstr. 6, 97080, Würzburg, Germany
  • Sabine Wittemer-Rump
    Bayer AG, SBU Oncology, Pharmaceuticals, 13353, Berlin, Germany
  • Gökben Koca
    Bayer AG, SBU Oncology, Pharmaceuticals, 13353, Berlin, Germany
  • Oliver Boix
    Bayer AG, SBU Oncology, Pharmaceuticals, 13353, Berlin, Germany
  • Wolf-Dietrich Döcke
    Bayer AG, SBU Oncology, Pharmaceuticals, 13353, Berlin, Germany
  • Ricarda Finnern
    Bayer AG, SBU Oncology, Pharmaceuticals, 13353, Berlin, Germany
  • Helena Kusi
    Bayer AG, SBU Oncology, Pharmaceuticals, 13353, Berlin, Germany
  • Antoinette Ajavon-Hartmann
    Bayer AG, SBU Oncology, Pharmaceuticals, 13353, Berlin, Germany
  • Sabine Stienen
    Research and Development, Amgen Research Munich GmbH, Staffelseestr. 2, 81477, Munich, Germany
  • Cyrus Michael Sayehli
    Department of Nuclear Medicine, University Hospital Würzburg, Oberdürrbacherstr. 6, D-97080, Würzburg, Germany
  • Bülent Polat
    Department of Radiation Oncology, University Hospital Würzburg, Josef-Schneider-Str. 11, 97080, Würzburg, Germany
  • Ralf C Bargou
    Translational Oncology, Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Josef-Schneider-Str. 6, 97080Würzburg, Germany

Journal

  • Immunotherapy

    Immunotherapy 13 (2), 125-141, 2020-11-10

    Informa UK Limited

Citations (1)*help

See more

Details 詳細情報について

Report a problem

Back to top